
Active Surveillance for Low-Risk PCa: Sprint or Marathon?
Philip Segal and Bruno Barrey were diagnosed with prostate cancer and opted for active surveillance to monitor but not treat the disease. Each has a different approach; Segal, at age 80, plans to maintain the status quo while Barrey, age 57, abandoned active surveillance after six months and opted for radiation therapy, as his cancer…